Cargando…

Surveillance, CDKN2A and survival of familial melanoma

Detalles Bibliográficos
Autor principal:	van Doorn, Remco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107663/ https://www.ncbi.nlm.nih.gov/pubmed/36640377 http://dx.doi.org/10.1111/jdv.18796

Ejemplares similares

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families
por: Potjer, Thomas P., et al.
Publicado: (2019)

Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers
por: Pissa, Maria, et al.
Publicado: (2022)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
por: Lesueur, F, et al.
Publicado: (2008)

Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway
por: Levin, Trine, et al.
Publicado: (2016)

Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations
por: Burke, Laura S., et al.
Publicado: (2013)

Genome-wide analysis of constitutional DNA methylation in familial melanoma
por: Salgado, Catarina, et al.
Publicado: (2020)

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families
por: Helgadottir, Hildur, et al.
Publicado: (2014)

Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants
por: Overbeek, Kasper A, et al.
Publicado: (2021)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
por: Torre, G Della, et al.
Publicado: (2001)

Analyzing Controversies in Management and Surveillance of Early-Stage Melanoma
por: Marushchak, Olga, et al.
Publicado: (2020)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants
por: Pauley, Kristen, et al.
Publicado: (2022)

Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients
por: Behrmann, Iris, et al.
Publicado: (2015)

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters
por: KARAGIANNI, Fani, et al.
Publicado: (2018)

PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis
por: Palmieri, Maria, et al.
Publicado: (2019)

Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort
por: Ibrahim, Isaura S., et al.
Publicado: (2023)

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Interaction of CDKN2A and Sun Exposure in the Etiology of Melanoma in the General Population
por: Berwick, Marianne, et al.
Publicado: (2011)

A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families
por: Goldstein, A M, et al.
Publicado: (2001)

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022)

CDKN2B Methylation Correlates with Survival in AML Patients
por: Kamali Dolatabadi, Esmat, et al.
Publicado: (2017)

Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention
por: Fan, Meiyun, et al.
Publicado: (2013)

Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma
por: Yang, H, et al.
Publicado: (2017)

Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new ‘revolutionary’ therapeutics?
por: Harvima, Ilkka T., et al.
Publicado: (2022)

Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023)

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients
por: Przybyła, Anna, et al.
Publicado: (2015)

Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History
por: O'Reilly, Mary, et al.
Publicado: (2021)

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours
por: Marian, C, et al.
Publicado: (2005)

Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma.
por: Platz, A., et al.
Publicado: (1996)

Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers
por: Christodoulou, E., et al.
Publicado: (2019)

CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study
por: Tovar-Parra, Jose D., et al.
Publicado: (2020)

Rapid regression of multiple melanocytic nevi in an individual with history of melanoma with the CDKN2A mutation
por: Jaber, Nor Fazil, et al.
Publicado: (2023)

Turner Syndrome, Atypical Naevi and Multiple Melanoma: Coincidence or Causality?
por: CLABBERS, Julia M. K., et al.
Publicado: (2023)

Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history
por: Chan, Andrew K., et al.
Publicado: (2017)

Recurrent melanoma development in a Caucasian female with CDKN2A+ mutation and FAMMM syndrome: A case report
por: Gu, Kaien, et al.
Publicado: (2020)

Global Surveillance, National Surveillance, and SARS
por: Heymann, David L., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_pc1j6edi689iqqc3qf3at510vi